Effectiveness of ETI Combination Therapy for N1303K CFTR Variant
Pubblicato da：Unknown
·Pubblicato il: 2025-12-13
Discussion regarding the effectiveness of Elexacaftor + Tezacaftor + Ivacaftor (ETI) combination therapy in restoring CFTR function specifically for Cystic Fibrosis patients with the N1303K variant.
Caricamento...